Literature DB >> 16902338

Pattern and factors affecting management outcome of spina bifida cystica in Ile-Ife, Nigeria.

O I Alatise1, A A Adeolu, E O Komolafe, O Adejuyigbe, O A Sowande.   

Abstract

BACKGROUND AND
OBJECTIVE: There is paucity of data on the pattern and factors affecting the management outcome of patients with spina bifida cystica in the Ife-Ijesa zone, Nigeria. This study was designed to address this research question.
METHOD: One hundred and six consecutive cases of spina bifida cystica who presented in our hospital from January 1990 to December 2004 were reviewed. We obtained information on sociodemographic factors, medical history and management as well as clinical outcome. SPSS was used to analyze the data. RESULT: Males constituted 54.7% and females 45.2% of cases. Mortality was high in those presented after the 4th week of life (p = 0.04). The malformation occurred in the lumbar and lumbosacral regions in 77.4%. Myelomeningocele was the most common type (86.8%). Hydrocephalus was recorded in 53.8% of patients. Surgical closure was done for 91.5% of the patients. About 77% of all the patients were discharged while 22.7% died. This was significantly related to age at presentation (p = 0.04) and infection before surgery (p = 0.045). Postoperative complications were more frequent in patients with ruptured lesions (p = 0.025), a larger size of defect (p = 0.028) and a lower birth weight (p = 0.006).
CONCLUSION: Myelomeningocele is the most common type of spina bifida cystica in our environment. Late presentation and preoperative infection are associated with high mortality in our patients. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902338     DOI: 10.1159/000094062

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  8 in total

Review 1.  Prevention of myelomeningocele: African perspectives.

Authors:  Taopheeq Bamidele Rabiu; Amos Olufemi Adeleye
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Author's reply: "How much do plastic surgeons add to the closure of myelomeningoceles?"

Authors:  Rhian Bevan; Paul Leach
Journal:  Childs Nerv Syst       Date:  2018-05-16       Impact factor: 1.475

3.  How much do plastic surgeons add to the closure of myelomeningoceles?

Authors:  Chiazor Udochukwu Onyia
Journal:  Childs Nerv Syst       Date:  2018-05-12       Impact factor: 1.475

4.  Applying a knowledge-to-action framework for primary prevention of spina bifida in tropical Africa.

Authors:  Kasereka M Claude; Kwibuka L Juvenal; Michael Hawkes
Journal:  Matern Child Nutr       Date:  2010-11-09       Impact factor: 3.092

5.  The pattern, peculiarities, and management challenges of spina bifida in a teaching hospital in Southwest Nigeria.

Authors:  Edward O Komolafe; Chiazor Udochukwu Onyia; Ibironke O Ogunbameru; Oluwamuyiwa A Dada; Oluwafemi F Owagbemi; Fred S Ige-Orhionkpaibima; Oluseun A Olarewaju; Efosa O Obamwonyi; Muhammad I Abdullahi
Journal:  Childs Nerv Syst       Date:  2017-10-12       Impact factor: 1.475

6.  The International Tethered Cord Partnership: Beginnings, process, and status.

Authors:  Celene B Mulholland; Guzmán Aranda; Luis Angel Arredondo; Erwin Calgua; Fernando Contreras; Dulce Maria Espinoza; Juan Bosco Gonzalez; Jose A Hoil; Edward Komolafe; Jorge A Lazareff; Yunhui Liu; Juan Luis Soto-Mancilla; Graciela Mannucci; Bao Nan; Santiago Portillo; Hongyu Zhao
Journal:  Surg Neurol Int       Date:  2011-03-23

7.  Maternal and neonatal serum zinc level and its relationship with neural tube defects.

Authors:  Arjun Chandra Dey; Mohammod Shahidullah; Mohammad Abdul Mannan; Mohammad Khaled Noor; Laxmi Saha; Shahana A Rahman
Journal:  J Health Popul Nutr       Date:  2010-08       Impact factor: 2.000

8.  Incidence of neural tube defects and their risk factors within a cohort of Moroccan newborn infants.

Authors:  Khenata Forci; El Arbi Bouaiti; Mohamed Hassan Alami; Asmaa Mdaghri Alaoui; Amal Thimou Izgua
Journal:  BMC Pediatr       Date:  2021-03-15       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.